EE05176B1 - Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities - Google Patents

Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities

Info

Publication number
EE05176B1
EE05176B1 EEP200200152A EEP200200152A EE05176B1 EE 05176 B1 EE05176 B1 EE 05176B1 EE P200200152 A EEP200200152 A EE P200200152A EE P200200152 A EEP200200152 A EE P200200152A EE 05176 B1 EE05176 B1 EE 05176B1
Authority
EE
Estonia
Prior art keywords
realities
tumor
antibody
structures
binding target
Prior art date
Application number
EEP200200152A
Other languages
Estonian (et)
Inventor
Schirner Michael
Licha Kai
Dinkelborg Ludger
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05176(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200152A publication Critical patent/EE200200152A/en
Publication of EE05176B1 publication Critical patent/EE05176B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EEP200200152A 1999-09-24 2000-08-19 Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities EE05176B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (en) 1999-09-24 1999-09-24 Antibody-dye conjugates against target structures of angiogenesis for intraoperative tumor border imaging
PCT/EP2000/008121 WO2001023005A1 (en) 1999-09-24 2000-08-19 Antibody dye conjugates for binding to target structures of angiogenesis in order to intraoperatively depict tumor peripheries

Publications (2)

Publication Number Publication Date
EE200200152A EE200200152A (en) 2003-04-15
EE05176B1 true EE05176B1 (en) 2009-06-15

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200152A EE05176B1 (en) 1999-09-24 2000-08-19 Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities

Country Status (23)

Country Link
EP (2) EP1214099A1 (en)
JP (1) JP2003510294A (en)
KR (2) KR100832937B1 (en)
CN (1) CN1269530C (en)
AU (1) AU779026B2 (en)
BG (1) BG65682B1 (en)
BR (1) BR0014192A (en)
CA (1) CA2385593A1 (en)
CZ (1) CZ2002991A3 (en)
DE (1) DE19947559A1 (en)
EE (1) EE05176B1 (en)
HK (1) HK1050491A1 (en)
HU (1) HUP0202625A2 (en)
IL (2) IL148405A0 (en)
MX (1) MXPA02002639A (en)
NO (1) NO20021441L (en)
NZ (1) NZ517944A (en)
RO (1) RO121598B1 (en)
RU (1) RU2002109237A (en)
SK (1) SK3972002A3 (en)
WO (1) WO2001023005A1 (en)
YU (1) YU20702A (en)
ZA (1) ZA200203225B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062800A1 (en) 2000-02-24 2001-08-30 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (en) * 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie USE OF ANTIBODIES TO TUMOR ASSOCIATED ANTIGEN
NO20034351D0 (en) * 2003-09-29 2003-09-29 Amersham Health As Optical imaging of endometriosis
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
EP2422187A4 (en) * 2009-04-21 2013-01-02 Univ Utah Res Found Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. Compositions and methods for detecting cancer cells in a tissue sample

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
ATE198712T1 (en) * 1994-07-11 2001-02-15 Univ Texas METHODS AND COMPOSITIONS FOR THE SPECIFIC COAGULATION OF TUMOR VESSELS
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
BG65682B1 (en) 2009-06-30
EP1532988A2 (en) 2005-05-25
WO2001023005A1 (en) 2001-04-05
EP1532988A3 (en) 2008-09-17
HK1050491A1 (en) 2003-06-27
BG106528A (en) 2002-12-29
CN1269530C (en) 2006-08-16
EE200200152A (en) 2003-04-15
NO20021441L (en) 2002-05-15
DE19947559A1 (en) 2001-04-19
NZ517944A (en) 2004-06-25
AU6702600A (en) 2001-04-30
YU20702A (en) 2005-06-10
CZ2002991A3 (en) 2002-06-12
ZA200203225B (en) 2003-07-23
JP2003510294A (en) 2003-03-18
KR100832937B1 (en) 2008-05-27
BR0014192A (en) 2002-05-21
AU779026B2 (en) 2005-01-06
RU2002109237A (en) 2003-11-27
KR20020039349A (en) 2002-05-25
IL148405A0 (en) 2002-09-12
CA2385593A1 (en) 2001-04-05
SK3972002A3 (en) 2002-09-10
HUP0202625A2 (en) 2002-12-28
PL354027A1 (en) 2003-12-15
CN1376074A (en) 2002-10-23
NO20021441D0 (en) 2002-03-22
RO121598B1 (en) 2007-12-28
EP1214099A1 (en) 2002-06-19
IL148405A (en) 2009-06-15
MXPA02002639A (en) 2002-07-30
KR20070087232A (en) 2007-08-27

Similar Documents

Publication Publication Date Title
NO20014105D0 (en) Texan derivatives for targeted cancer therapy
ATE370748T1 (en) ERYTHROPOIETIN DERIVATIVES
EE200200673A (en) Quinazoline derivatives for the treatment of tumors
DE60009147D1 (en) ADMANTAN DERIVATIVES
IS2468B (en) Methods and Intermediates for the Preparation of Cancer Compounds
ATE326470T1 (en) NEW AZA-INDOLYL DERIVATIVES
NO20021400D0 (en) Therapeutic conazoline derivatives
DE60013127D1 (en) 5-PHENYL-PYRIMIDINE DERIVATIVES
PT1173187E (en) COMBINED PREPARATIONS UNDERSTANDING ANTRACCYCLINE DERIVATIVES
DK0942754T3 (en) Conjugates useful for the treatment of prostate cancer
ATE273980T1 (en) 6-PHENYLPYRROLOPYRIMIDINDONE DERIVATIVES
DE69829350D1 (en) directional coupler
NO20022245D0 (en) Oncolytic combinations for the treatment of cancer
EE05176B1 (en) Antibody-v Dye Conjugates for Binding Target Angiogenesis Structures for Intraoperative Visualization of Tumor Realities
ATE317389T1 (en) 4-PHENYL-PYRIMIDINE DERIVATIVES
DE60129174D1 (en) NEW PLEUROMUTILINE DERIVATIVES
EP1208232A4 (en) Markers for prostate cancer
DE60143905D1 (en) PHTALAZINONE DERIVATIVES
DE59909108D1 (en) directional coupler
DE50010954D1 (en) Phosphate-containing pigment preparations
DE60103859D1 (en) 2-PHENYLPYRAN-4-ON DERIVATIVES
PT1030319E (en) TOROIDAL NUCLEUS
FIU990263U0 (en) Cancer needle
AR027857A1 (en) IMPROVED ABSORBENT NUCLEUS
DK1136622T3 (en) Track coverage

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20090819